Activity Details

Target Audience

This activity has been designed to meet the educational needs of radiologists and other health care professionals involved in the diagnosis, treatment and management of patients with autosomal dominant polycystic kidney disease (ADPKD).

Overview

This Expert Exchange webcast is designed to help clinicians better understand the importance of radiologic imaging in the clinical management of patients affected by ADPKD.

Educational Objectives

Upon completion of this activity, participants will be better able to do the following:

• Recognize the significance of total kidney volume (TKV) in ADPKD
• Summarize the methods for assessing TKV
• Recognize atypical vs. typical presentations of PKD
• Summarize clinical decision-making steps regarding treatment decisions

Faculty

Bohyun Kim, MD, PhD
Chief, GU Section
Professor of Radiology
Mayo Clinic
Rochester, MN

Anjay Rastogi, MD, PhD
Director, PKD Program and CORE Kidney Program
Professor and Clinical Chief, Nephrology
UCLA Geffen School of Medicine
Los Angeles, CA

Financial Support

This activity has been supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.

Providers

Jointly provided by the University of Florida College of Medicine and Novus Medical Education.

Joint Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and Novus Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Physician Continuing Medical Education

The University of Florida College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

The University of Florida College of Medicine requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to UF COM policy. UF COM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty
Dr. Kim reports no relevant financial relationships to disclose.
Dr. Rastogi reports the following relevant financial relationships:

• Speakers Bureau/Advisory Board - Genzyme/Sanofi, Otsuka
• Research Support - Kadmon, Reata Pharmaceuticals, Sanofi

Planners and Managers
The UF COM and Novus Medical Education planners and managers have nothing to disclose.

Method of Participation

There are no fees for participating and receiving CME credit for this activity. To claim credit, participants must complete the following:

• Read the educational objectives, accreditation information and faculty disclosures at the beginning of this activity.
• Complete the pre-test.
• View the webcast.
• Complete the post-test and evaluation.
• Physicians who receive a grade of 80% or better on the post-test and complete the evaluation will receive a CME certificate.
• All other participants who receive a grade of 80% or better on the post-test and complete the evaluation will receive a Certificate of Participation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CME Provider

The University of Florida College of Medicine can be contacted at cme-mail@ufl.edu or 352.733.0064.